Thursday, December 25, 2025
ADVT 
National

Feds run $24B deficit over April and May

Darpan News Desk The Canadian Press, 30 Jul, 2021 10:19 AM
  • Feds run $24B deficit over April and May

The federal government ran a deficit of nearly $24 billion over the first two months of its fiscal year, a sharp drop from the unprecedented spending one year earlier at the start of the COVID-19 pandemic.

The Finance Department's regular fiscal monitor says the budgetary deficit over April and May was $23.8 billion, down from the $86.8 billion recorded over the same months in 2020.

The department's report says the drop in spending was expected given the improved conditions from last spring when the economy had a historic slide, prompting the federal treasury to pump out an unprecedented amount of emergency aid.

The fiscal monitor says the deficit now reflects ongoing economic challenges, including the effect of third-wave lockdowns and ongoing spending on emergency aid that is scheduled to wrap up this fall.

Program spending, excluding net actuarial losses, was almost $76.9 billion over April and May, a decline of about $37 billion, or a 32.5 per cent drop, from the $113.8 billion in the same period one year earlier.

Revenues reached over $59.5 billion over April and May, which was a $27.1-billion, or 83.6 per cent, year-over-year increase from the $32.4 billion in the previous fiscal year.

The fiscal monitor says the result is largely due to the steep drop in tax revenues at the onset of the pandemic as large parts of the economy were shuttered.

Public debt charges increased by $300 million, or 9.1 per cent, to $3.9 billion from the almost $3.6 billion in the previous fiscal year.

The Finance Department says the change is due to higher inflation adjustments on real return bonds, offset partially by lower interest on treasury bills and the government's pension and benefit obligations.

MORE National ARTICLES

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety
Police agencies throughout the Lower Mainland are aware of several conflicts involving numerous crime groups that have resulted in murders and attempted murders in recent weeks in public places. Police are expecting the violence to continue and escalate.

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety

411 COVID19 cases for Tuesday

411 COVID19 cases for Tuesday
There are 4,890 active cases of COVID-19 in the province. A further 133,383 people who tested positive have recovered. There have been two new COVID-19 related deaths, for a total of 1,650 deaths in British Columbia.

411 COVID19 cases for Tuesday

Trudeau tamps down talk of reopening U.S. border

Trudeau tamps down talk of reopening U.S. border
Trudeau acknowledges that discussions about the border are ongoing, but he's tamping down any expectations that travel restrictions could be lifted soon.

Trudeau tamps down talk of reopening U.S. border

Environmentalists happy with energy agency report

Environmentalists happy with energy agency report
The report, released Tuesday, says there is a narrow but viable pathway for a global energy sector with net-zero greenhouse gas emissions by 2050.

Environmentalists happy with energy agency report

PM wants ceasefire in Israeli-Palestinian conflict

PM wants ceasefire in Israeli-Palestinian conflict
He says the violence needs to stop and Canada will work with the international community to de-escalate the situation "so that there is no more loss of civilian life."

PM wants ceasefire in Israeli-Palestinian conflict

Second dose choice likely for AstraZeneca: Tam

Second dose choice likely for AstraZeneca: Tam
Tam's comments Tuesday come hours after a small Spanish study on mixing and matching vaccines reported that giving a Pfizer-BioNTech for the second dose after AstraZeneca is safe and produced a stronger immune response than a second dose of AstraZeneca.

Second dose choice likely for AstraZeneca: Tam